Literature DB >> 9689620

Cerebellar involvement in metabolic disorders: a pattern-recognition approach.

M Steinlin1, S Blaser, E Boltshauser.   

Abstract

Inborn errors of metabolism can affect the cerebellum during development, maturation and later during life. We have established criteria for pattern recognition of cerebellar abnormalities in metabolic disorders. The abnormalities can be divided into four major groups: cerebellar hypoplasia (CH), hyperplasia, cerebellar atrophy (CA), cerebellar white matter abnormalities (WMA) or swelling, and involvement of the dentate nuclei (DN) or cerebellar cortex. CH can be an isolated typical finding, as in adenylsuccinase deficiency, but is also occasionally seen in many other disorders. Differentiation from CH and CA is often difficult, as in carbohydrate deficient glycoprotein syndrome or 2-L-hydroxyglutaric acidaemia. In cases of atrophy the relationship of cerebellar to cerebral atrophy is important. WMA may be diffuse or patchy, frequently predominantly around the DN. Severe swelling of white matter is present during metabolic crisis in maple syrup urine disease. The DN can be affected by metabolite deposition, necrosis, calcification or demyelination. Involvement of cerebellar cortex is seen in infantile neuroaxonal dystrophy. Changes in DN and cerebellar cortex are rather typical and therefore most helpful; additional features should be sought as they are useful in narrowing down the differential diagnosis.

Entities:  

Mesh:

Year:  1998        PMID: 9689620     DOI: 10.1007/s002340050597

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  15 in total

1.  The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a.

Authors:  P Feraco; M Mirabelli-Badenier; M Severino; M G Alpigiani; M Di Rocco; R Biancheri; A Rossi
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

Review 2.  Inherited cerebellar ataxia in childhood: a pattern-recognition approach using brain MRI.

Authors:  L Vedolin; G Gonzalez; C F Souza; C Lourenço; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

3.  Descriptive epidemiology of cerebellar hypoplasia in the National Birth Defects Prevention Study.

Authors:  Meredith M Howley; Kim M Keppler-Noreuil; Christopher M Cunniff; Marilyn L Browne
Journal:  Birth Defects Res       Date:  2018-09-19       Impact factor: 2.344

4.  Disruption of cerebellar development: potential complication of extreme prematurity.

Authors:  Agnes Messerschmidt; Peter C Brugger; Eugen Boltshauser; Gerlinde Zoder; Walter Sterniste; Robert Birnbacher; Daniela Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

5.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.

Authors:  P Jouvet; P Rustin; D L Taylor; J M Pocock; U Felderhoff-Mueser; N D Mazarakis; C Sarraf; U Joashi; M Kozma; K Greenwood; A D Edwards; H Mehmet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

6.  Diagnostic approach to childhood-onset cerebellar atrophy: a 10-year retrospective study of 300 patients.

Authors:  Almundher Al-Maawali; Susan Blaser; Grace Yoon
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

7.  Analysis and classification of cerebellar malformations.

Authors:  Sandeep Patel; A James Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

8.  Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability.

Authors:  Lubov Blumkin; Esther Leshinsky-Silver; Ayelet Zerem; Keren Yosovich; Tally Lerman-Sagie; Dorit Lev
Journal:  JIMD Rep       Date:  2013-09-19

9.  Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.

Authors:  Thais C Vilela; Giselli Scaini; Camila B Furlanetto; Matheus A B Pasquali; João Paulo A Santos; Daniel P Gelain; José Cláudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-08-11       Impact factor: 3.584

10.  Movement disorders in adult surviving patients with maple syrup urine disease.

Authors:  Miryam Carecchio; Susanne A Schneider; Heidi Chan; Robin Lachmann; Philip J Lee; Elaine Murphy; Kailash P Bhatia
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.